Corporate

  • September 22, 2026

    UMass Hospital Co. Beats Ex-VP's COVID Vaccine Firing Claim

    A jury cleared a central Massachusetts hospital system of liability for terminating a compliance officer who refused a COVID-19 shot, finding Tuesday she failed to show a sincere religious belief against vaccination.

  • September 22, 2026

    SEC Fines Broker-Dealer Over System Security Failures

    The U.S. Securities and Exchange Commission on Tuesday ordered OTC Link LLC to pay $575,000 over allegations that the New York-based broker-dealer did not establish and enforce policies to ensure the security of the technology underpinning one of its alternative trading systems, despite several citations from examiners.

  • September 22, 2026

    'Yikes' Email Sinks BIPA Coverage For Donut, Transport Cos.

    An email stating "Yikes ... no" in response to outside counsel's inquiry regarding a commercial bakery's biometric data collection practices proves the business and a logistics company misrepresented material facts while seeking insurance that could have covered an underlying privacy dispute, an Illinois federal judge said Monday.

  • September 22, 2026

    CVS Beats Malpractice Suit Over Pharmacy Mix-Up

    A California appeals court on Tuesday upheld the dismissal of a suit accusing a CVS pharmacy of negligently giving the wrong prescription medication to a woman, which allegedly caused years of seizures, citing flawed expert testimony from plaintiff's expert.

  • September 22, 2026

    OppFi SPAC Investors Get OK For $13M Post-IPO Flop Deal

    The Delaware Chancery Court on Tuesday approved a $13 million settlement to end litigation accusing special purpose acquisition company FG New America Acquisition Corp. and several of its executives and directors of overselling the value of merger target Opportunity Financial, whose stocks plummeted by some 80% after the take-public transaction.

  • September 22, 2026

    FDA Must Revisit MiMedx Wound Care Powder Classification

    A Georgia federal judge vacated the Food and Drug Administration's classification of biomedical company MiMedx's wound care treatment as a biological product, which carries heightened regulatory requirements, finding the agency's determination was arbitrary because it had classified similar products as devices.

  • September 22, 2026

    Lender's $8.1M In Losses Were 'Self-Inflicted,' 11th Circ. Told

    The former CEO of a lender that financed independent insurance marketers has urged the Eleventh Circuit to reverse an $8.1 million trial judgment for breaching his work terms, arguing that the damages sustained by his previous employer were "self-inflicted." 

  • September 22, 2026

    Amazon Says Ring Cam Privacy Suit Misconstrues State Laws

    Amazon urged a Washington federal judge Monday to throw out a proposed class action claiming its Ring doorbell security cameras illegally gathered facial recognition data of neighbors and visitors, contending the plaintiffs seek "to rewrite states' privacy laws" and invent new private rights of action.

  • September 22, 2026

    8th Circ. Asked To Nix Fraud Tax Credit Suit, $90M Judgment

    A man accused of helping form a sham limited liability company that fraudulently received millions in alternative fuel mixture tax credits asked the Eighth Circuit on Tuesday to reverse a judgment of more than $90 million against him, saying he shouldn't be personally liable for the company's conduct.

  • September 22, 2026

    Alphabet's Bid To Pare Ad Tech Suit Stalls Over Discovery

    A California federal judge rejected Alphabet's bid for partial summary judgment, saying the Google parent must first comply with a class of investors' discovery requests prompted by the company's motion in litigation claiming CEO Sundar Pichai made a false statement to Congress about whether the company's ad auctions favor Facebook.

  • September 22, 2026

    UiPath Execs, Investor Clash Over Bid To Ax Derivative Suit

    UiPath Inc.'s directors and executives urged the Delaware Chancery Court on Tuesday to throw out a shareholder derivative suit accusing them of misleading investors and trading on inside information, while shareholder Scott Rudolph argued the board was too conflicted to fairly decide whether the company should pursue the claims itself.

  • September 22, 2026

    Foley & Lardner Steers Cognex On $500M RealSense Buy

    Industrial machine-vision company Cognex Corp. said Tuesday it has agreed to acquire RealSense for about $500 million, expanding its business into robotic perception and adding exposure to the growing market for 3D sensing technology.

  • September 22, 2026

    Jackson Lewis Launches AI Practice Group, Resource Hub

    Management-side labor and employment firm Jackson Lewis PC announced Monday that it has launched an artificial intelligence and innovation group to help clients navigate an evolving legal and regulatory landscape.

  • September 22, 2026

    DoorDash To Pay $131.5M To Settle NYC Delivery Pay Probe

    DoorDash will pay $131.5 million to settle a New York City investigation that found it underpaid workers, paid some late and excluded certain trip and waiting time from minimum-pay calculations, with more than 200,000 workers set to receive payments, the city announced Tuesday.

  • September 21, 2026

    Teddy's Says Buc-ee's TM Campaign Violates Antitrust Law

    Teddy's Market has escalated its counterclaims against Buc-ee's in Georgia federal court with allegations of antitrust violations, claiming the travel-center chain uses trademark infringement lawsuits to unlawfully expand its control over cartoon-animal branding in the convenience store industry.

  • September 21, 2026

    ADM Faces Class Action Over Purported Dark Web Data Leak

    A former Archer-Daniels-Midland Co. employee filed a proposed class action in Illinois federal court claiming the agricultural giant failed to protect workers' personal information during a ransomware attack this month that has been attributed to a cybercrime group.

  • September 21, 2026

    Starbucks Investors Allege $227.5M In Buyback Losses

    Two Starbucks shareholders have brought a derivative suit in Washington federal court accusing the company's leadership of hyping its performance in the U.S. and China even as sales declined, and of losing $227.5 million buying back its own stock at inflated prices. 

  • September 21, 2026

    Meta Trims But Can't End Cybersecurity Pro's Retaliation Suit

    The former head of cybersecurity at messaging platform WhatsApp can pursue some, but not all, of his whistleblower retaliation suit against Meta Platforms, a California federal judge has ruled, saying the complaint plausibly alleges protected activity regarding his reports that claim Meta violated U.S. Securities and Exchange Commission rules.

  • September 21, 2026

    Ex-PetIQ CEO's Brother Admits To Illicit Trades Over Deal Info

    An Idaho man pled guilty Monday in federal court to trading on confidential information he received from his brother, the former CEO of PetIQ, about the company's acquisition by Bansk Group in August 2024.

  • September 21, 2026

    Endeavor, Silver Lake Sue To Block Appraisal Claims

    Endeavor Group Holdings Inc. and Silver Lake Technology Management LLC on Monday sued dozens of hedge funds and other investors in Delaware Chancery Court, seeking to block them from pursuing appraisal claims over Silver Lake's $27.50 per-share buyout of Endeavor and alleging that many bought shares only after the deal was announced to profit from litigation.

  • September 21, 2026

    Catching Up With Delaware's Chancery Court

    The Delaware Chancery Court this past week dismissed a challenge to Alteryx Inc.'s $4.4 billion take-private sale, resolved a fight over the removal of a security technology company's director and declined to let Empery Digital Inc. immediately appeal a proxy contest ruling.

  • September 21, 2026

    Judge Reduces $38.9M Beyond Meat TM Verdict

    A Massachusetts judge slashed a $38.9 million trademark infringement verdict against Beyond Meat Inc. for an advertising campaign that used the slogan "Great Taste, Plant Based" after finding that the trademark owner failed to prove all of its damages.

  • September 21, 2026

    Regeneron Investors Can't Use FCA Action To Support Suit

    Regeneron Pharmaceuticals Inc. and its executives have beaten a proposed class action accusing them of misleading investors about the company's revenue prospects for its vision loss drug and inflating reimbursements, with a judge ruling that the suit does not use the U.S. Department of Justice's False Claims Act suit against the company to plead share losses.

  • September 21, 2026

    Willkie Hires Ex-Gibson Dunn Energy Pro In Paris

    Willkie Farr & Gallagher LLP has picked ex-Gibson Dunn & Crutcher LLP attorney Pauline Portos for an energy and infrastructure-focused partner role in its Paris office, the firm announced.

  • September 21, 2026

    Greenberg Traurig Adds Kirkland Finance Pro In Dallas

    Greenberg Traurig LLP announced Monday that it has added a Dallas-based shareholder to its finance practice who came aboard from Kirkland & Ellis LLP.

Expert Analysis

  • $100M Clean Air Act Ruling Transforms Parent Co. Liability

    Author Photo

    A Michigan federal court's recent decision in U.S. v. EES Coke Battery, holding a company liable for Clean Air Act violations at a plant owned by its subsidiary, weakens the legal shield between businesses and their corporate parents, and has started a legal battle that may last for years, say attorneys at Haynes Boone.

  • Series

    Mich. Banking Brief: All The Notable Legal Updates In Q2

    Author Photo

    The second quarter brought several notable financial services law developments to Michigan, including a U.S. Supreme Court ruling on state tax foreclosures, progress on a money transmission modernization bill package, and continued legislative momentum on cryptocurrency and mortgage lending, say attorneys at Dykema.

  • A New Regulatory Environment For PE In Calif. Healthcare

    Author Photo

    The California Office of Health Care Affordability's proposed revisions to its cost and market impact review regulations, amid broader state scrutiny of private equity-backed healthcare arrangements, represent a qualitative shift in California's regulatory posture toward institutional healthcare investment, say attorneys at Ropes & Gray.

  • CFIUS' Mandate Misses Foreign Risk In Project Subcontracts

    Author Photo

    Recent calls for the Committee on Foreign Investment in the United States to review equity transactions like the Paramount Skydance-Warner Bros. deal miss a consequential oversight gap — CFIUS' inability to review the subcontracting layer of U.S. infrastructure projects, says Thibaut Giret at Alstef Group.

  • AI Governance Tips For Avoiding Securities Suits

    Author Photo

    A recent securities class action in California federal court against lending platform Upstart highlights how statements about artificial intelligence are increasingly being scrutinized not only by regulators, but also by shareholders, meaning companies should ensure oversight frameworks keep pace with the technology, say attorneys at Akerman.

  • Lessons From The DOJ's 1st Enforcement Policy Declination

    Author Photo

    The first U.S. Department of Justice declination to prosecute alleged export control violations and national security offenses offers a window into the operation of the administration’s recently implemented corporate enforcement and voluntary self‑disclosure policy, and how companies' compliance and cooperation efforts should be targeted, say attorneys at Pillsbury.

  • Series

    Bass Fishing Makes Me A Better Lawyer

    Author Photo

    Landing a trophy striped bass and closing a big deal both require cultivating the patience to finesse — not force — your way to desired outcomes, changing course when your old approach isn’t working and learning from the ones that got away, says Jon Ruiss at Alston & Bird.

  • What Consent Decree Trends Mean For Deal Clearances

    Author Photo

    With merger remedies back on the table under the current administration, an analysis of recent Federal Trade Commission and U.S. Department of Justice consent decrees reveals that prior approval and prior notice provisions are no longer a foregone conclusion, and companies may be able to negotiate narrowly tailored obligations, say attorneys at Weil.

  • Series

    NY Banking Brief: All The Notable Legal Updates In Q2

    Author Photo

    The year's second quarter brought several notable banking law developments to New York, including a proposal to align state stablecoin rules with the federal Genius Act, fresh fair lending and cybersecurity guidance from state regulators, and a significant Second Circuit holding on preemption, say attorneys at Ashurst Perkins Coie.

  • How Reincorporating In Texas May Alter Earnout Disputes

    Author Photo

    While the DExit debate has focused on shareholder suits, far less attention has been paid to what reincorporating in Texas means for M&A disputes, making it particularly important to understand the nuances between Delaware and Texas earnout jurisprudence, say attorneys at Selendy Gay.

  • Roundup

    The Most Talked-About Supreme Court Decisions Of 2026

    Author Photo

    This term, 11 U.S. Supreme Court decisions quickly became hot topics among Law360's guest writers.

  • Structuring Space Nuclear Deals For Regulatory Risk

    Author Photo

    With the White House's recent focus on space nuclear power, a highly important question for companies that want to build orbital reactors, lunar surface systems or critical components is whether the transaction documents can handle foreign investment constraints, export controls and treaty-linked liability, says Kristie Blase at Frazer + Blase.

  • What Durnell Ruling Means For Mo. Roundup Settlement

    Author Photo

    While the U.S. Supreme Court’s recent ruling in Monsanto v. Durnell forecloses the failure-to-warn theory that carried most of the claims against Monsanto in a pending class action in Missouri state court, it leaves untouched the question of whether the class was assembled merely to contain the defendant's liability, says attorney Gregg Goldfarb.

  • Texas Business Court Rulings Show Deal Terms Paramount

    Author Photo

    As the courts within the Texas Business Court system have begun reaching the substantive merits of the cases before them, they are persuasively demonstrating they will not only enforce the terms of transactions as written, but will also embrace a holistic approach to complex transaction documentation interpretation, says Christopher Pace at Winston Taylor.

  • Agentic AI And Securities Law: Who Is The Adviser?

    Author Photo

    Securities regulation has always been actor-based, but as agentic artificial intelligence becomes more common, it will push the law toward a partially system-based framework in which systems themselves, and the relationships between them and their deployers, are the focus of regulatory attention, says Joseph A. Hall at Davis Polk.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Corporate archive.